Back

Mitigating the Opioid Epidemic: The Role of Cannabinoids in Chronic Pain Management - A Systematic Review and Meta-Analysis of Clinical Evidence and Mechanisms

Borges, J. Y. V.

2024-08-01 pain medicine
10.1101/2024.07.14.24310378
Show abstract

Background and ObjectivesAs the medical community seeks alternative pain management strategies, cannabinoids have emerged as a potential option. This review discusses the role of cannabinoids in chronic pain management and their potential as an alternative treatment in pain medicine, focusing on efficacy, safety, and possible opioid reduction. The objectives are to evaluate the efficacy and safety of cannabinoids in chronic pain management, explore their potential to reduce opioid use, and identify the mechanisms by which cannabinoids exert their analgesic effects. Additionally, the review seeks to highlight the clinical implications and limitations of using cannabinoids as an alternative to opioids. MethodsA comprehensive literature review and meta-analysis were conducted, focusing on studies from PubMed, MEDLINE, and Cochrane, focusing on various types of studies. Data were extracted and analyzed to assess the efficacy, safety, and potential opioid-sparing effects of cannabinoids. Mechanistic insights were also explored to understand how cannabinoids modulate pain. ResultsCannabinoids have shown efficacy in managing chronic pain, with evidence indicating their ability to reduce pain and improve quality of life. Studies suggest that cannabinoids can provide significant analgesic effects, although there is variability in efficacy across trials. Findings also show that Cannabinoids modulate pain through the endocannabinoid system, which plays a crucial role in pain perception and inflammation. LimitationsThe variability in efficacy across studies suggests a need for standardized formulations and dosing regimens. Long-term effects of cannabinoid use are not fully understood, necessitating further research. More high-quality trials are needed to confirm findings and address potential biases. ConclusionCannabinoids offer a promising alternative for chronic pain management, with the potential to mitigate the opioid epidemic. Integrating cannabinoids into clinical practice, guided by evidence-based protocols, can provide a safer and effective approach to chronic pain management.

Matching journals

1
Pain
Ovid Technologies (Wolters Kluwer Health) · based on 15 published papers
Top 0.2%
130× avg
2
Clinical Pharmacology & Therapeutics
Wiley · based on 19 published papers
Top 0.2%
108× avg
3
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 44%
11.4%
4
Neuroscience & Biobehavioral Reviews
Elsevier BV · based on 19 published papers
#1
90× avg
5
The Journal of Pain
Elsevier BV · based on 11 published papers
Top 0.3%
100× avg
6
BMC Neurology
Springer Science and Business Media LLC · based on 11 published papers
#1
66× avg
7
Frontiers in Human Neuroscience
Frontiers Media SA · based on 11 published papers
Top 0.3%
67× avg
8
Clinical and Translational Science
Wiley · based on 14 published papers
Top 0.2%
51× avg
9
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 49%
3.0%
10
BMJ Open
BMJ · based on 553 published papers
Top 36%
2.4%
11
Frontiers in Immunology
Frontiers Media SA · based on 140 published papers
Top 4%
4.9× avg
12
Frontiers in Pharmacology
Frontiers Media SA · based on 27 published papers
Top 3%
7.4× avg
13
British Journal of Anaesthesia
Elsevier BV · based on 13 published papers
Top 2%
9.6× avg
14
Neuropsychopharmacology
Springer Science and Business Media LLC · based on 29 published papers
Top 3%
10× avg
15
Frontiers in Neurology
Frontiers Media SA · based on 74 published papers
Top 10%
1.9× avg
16
Blood Advances
American Society of Hematology · based on 16 published papers
Top 1%
10× avg
17
Frontiers in Genetics
Frontiers Media SA · based on 32 published papers
Top 5%
4.5× avg
18
Brain Sciences
MDPI AG · based on 19 published papers
Top 2%
11× avg
19
Epidemiology and Psychiatric Sciences
Cambridge University Press (CUP) · based on 10 published papers
Top 1%
14× avg
20
Frontiers in Neuroscience
Frontiers Media SA · based on 29 published papers
Top 4%
5.2× avg